Kenvue Inc. logo

Kenvue Inc. (J4D)

Market Open
4 Dec, 18:30
XDUS XDUS
14. 52
+0.17
+1.21%
- Market Cap
21.62 P/E Ratio
0.8% Div Yield
0 Volume
1.14 Eps
14.34
Previous Close
Day Range
14.34 14.52
Year Range
11.94 22.77
Want to track J4D and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 61 days

Summary

J4D trading today higher at €14.52, an increase of 1.21% from yesterday's close, completing a monthly increase of 17.92% or €2.21. Over the past 12 months, J4D stock lost -29.39%.
J4D pays dividends to its shareholders, with the most recent payment made on Nov 26, 2025. The next estimated payment will be in In 2 months on Feb 26, 2026 for a total of €0.2075.
The last earnings report, released on Nov 06, 2025, missed the consensus estimates by -0.26%. On average, the company has fell short of earnings expectations by -0.2%, based on the last three reports. The next scheduled earnings report is due on Feb 04, 2026.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

J4D Chart

US appeals court to weigh reviving cases over Tylenol and autism

US appeals court to weigh reviving cases over Tylenol and autism

A U.S. appeals court is expected to hear arguments on Monday from families seeking to revive their lawsuits over Tylenol, after the Trump administration publicly promoted their claims that the popular painkiller is linked to autism in children.

Reuters | 2 weeks ago
Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

A Texas judge on Friday will consider state Attorney General Ken Paxton's bid to block Kenvue from paying a $398 million dividend to shareholders and from marketing Tylenol as safe for pregnant women.

Reuters | 3 weeks ago
Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Texas Attorney General Ken Paxton on Thursday asked a state judge to block Kenvue from paying a nearly $400 million shareholder dividend this month, after suing the drugmaker for allegedly concealing risks to children from the use of Tylenol by pregnant women.

Reuters | 4 weeks ago

Kenvue Inc. (J4D) FAQ

What is the stock price today?

The current price is €14.52.

On which exchange is it traded?

Kenvue Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is J4D.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.8%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 04, 2026.

Has Kenvue Inc. ever had a stock split?

No, there has never been a stock split.

Kenvue Inc. Profile

- Industry
- Sector
Kirk L. Perry CEO
XDUS Exchange
US49177J1025 ISIN
US Country
22,000 Employees
12 Nov 2025 Last Dividend
- Last Split
4 May 2023 IPO Date

Overview

Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.

Products and Services

  • Self Care: This segment encompasses products for cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and more. Notable brands include Tylenol for pain relief, Motrin for inflammation, Benadryl for allergies, Nicorette for smoking cessation, Zarbee's and ORSLTM for general wellness, Rhinocort for nasal congestion, Calpol for children's fever and pain, and Zyrtec for 24-hour allergy relief.
  • Skin Health and Beauty: Dedicated to maintaining skin health and enhancing beauty, this segment offers products for face and body care, hair care, sun protection, and more. It includes Neutrogena for skincare and acne treatment, Aveeno for moisturizers with natural ingredients, Dr.Ci:Labo for innovative skin solutions, Le Petit Marseillais for shower gels and soaps with enchanting fragrances, Lubriderm for daily moisture, Rogaine for hair regrowth, and OGX for salon-inspired hair care.
  • Essential Health: Focusing on essential healthcare needs, this segment provides oral care, baby care, women's health, wound care, among other products. It features Listerine for oral health, Johnson's products for baby care, Band-Aid for wound protection, Stayfree pads, o.b. tampons, and Carefree liners for feminine hygiene, as well as Desitin Diaper Rash cream to soothe and protect infants.

Contact Information

Address: 199 Grandview Road
Phone: (732) 524-0400